497 related articles for article (PubMed ID: 37151876)
1. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q
Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876
[TBL] [Abstract][Full Text] [Related]
2. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
3. High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites.
Yang J; Wei H; Zhou Y; Szeto CH; Li C; Lin Y; Coker OO; Lau HCH; Chan AWH; Sung JJY; Yu J
Gastroenterology; 2022 Jan; 162(1):135-149.e2. PubMed ID: 34461052
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Berberine on the Gut Microbiota in Apc
Wang H; Guan L; Li J; Lai M; Wen X
Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580
[No Abstract] [Full Text] [Related]
5. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
Front Immunol; 2020; 11():588079. PubMed ID: 33072135
[TBL] [Abstract][Full Text] [Related]
6. Anti-obesity and Gut Microbiota Modulation Effect of Astragalus Polysaccharides Combined with Berberine on High-Fat Diet-Fed Obese Mice.
Yue SJ; Wang WX; Zhang L; Liu J; Feng WW; Gao H; Tang YP; Yan D
Chin J Integr Med; 2023 Jul; 29(7):617-625. PubMed ID: 34921647
[TBL] [Abstract][Full Text] [Related]
7. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
Shi Y; Hu J; Geng J; Hu T; Wang B; Yan W; Jiang Y; Li J; Liu S
Biomed Pharmacother; 2018 Nov; 107():1556-1563. PubMed ID: 30257374
[TBL] [Abstract][Full Text] [Related]
8. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites.
Jing W; Dong S; Luo X; Liu J; Wei B; Du W; Yang L; Luo H; Wang Y; Wang S; Lu H
Pharmacol Res; 2021 Feb; 164():105358. PubMed ID: 33285228
[TBL] [Abstract][Full Text] [Related]
9. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression.
Yang YN; Wang QC; Xu W; Yu J; Zhang H; Wu C
Biomed Pharmacother; 2022 Nov; 155():113749. PubMed ID: 36174380
[TBL] [Abstract][Full Text] [Related]
10. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe
Zhu L; Zhang D; Zhu H; Zhu J; Weng S; Dong L; Liu T; Hu Y; Shen X
Atherosclerosis; 2018 Jan; 268():117-126. PubMed ID: 29202334
[TBL] [Abstract][Full Text] [Related]
11. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids.
Yue SJ; Liu J; Wang AT; Meng XT; Yang ZR; Peng C; Guan HS; Wang CY; Yan D
Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E73-E85. PubMed ID: 30422704
[TBL] [Abstract][Full Text] [Related]
12. Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota.
Deng J; Zhao L; Yuan X; Li Y; Shi J; Zhang H; Zhao Y; Han L; Wang H; Yan Y; Zhao H; Wang H; Zou F
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215376
[TBL] [Abstract][Full Text] [Related]
13. Traditional Medicine Xianglian Pill Suppresses high-fat diet-related colorectal cancer via inactivating TLR4/MyD88 by remodeling gut microbiota composition and bile acid metabolism.
Ye C; Wu C; Li Y; Chen C; Li X; Zhang J; Xu Z; Chen H; Guo Y
J Ethnopharmacol; 2024 May; ():118411. PubMed ID: 38824980
[TBL] [Abstract][Full Text] [Related]
14. Berberine suppresses colorectal cancer by regulation of Hedgehog signaling pathway activity and gut microbiota.
Sun Q; Yang H; Liu M; Ren S; Zhao H; Ming T; Tang S; Tao Q; Chen L; Zeng S; Duan DD; Xu H
Phytomedicine; 2022 Aug; 103():154227. PubMed ID: 35679795
[TBL] [Abstract][Full Text] [Related]
15. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.
Fang Y; Zhang J; Zhu S; He M; Ma S; Jia Q; Sun Q; Song L; Wang Y; Duan L
Pharmacol Res; 2021 Mar; 165():105439. PubMed ID: 33493658
[TBL] [Abstract][Full Text] [Related]
16. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.
Xu X; Zhu XP; Bai JY; Xia P; Li Y; Lu Y; Li XY; Gao X
FASEB J; 2019 Jun; 33(6):7289-7300. PubMed ID: 30848932
[TBL] [Abstract][Full Text] [Related]
17. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
Yao Y; Chen H; Yan L; Wang W; Wang D
Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
[TBL] [Abstract][Full Text] [Related]
19. The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats.
Dai Y; Zhu W; Zhou J; Shen T
Braz J Med Biol Res; 2022; 55():e12096. PubMed ID: 35584453
[TBL] [Abstract][Full Text] [Related]
20. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]